1338 related articles for article (PubMed ID: 27987518)
21. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
[TBL] [Abstract][Full Text] [Related]
22. Sight-Threatening Unilateral Posterior Scleritis With Positive Atypical p-ANCA As Early Manifestation of Lupus Spectrum Disease.
Chew LL; See W; Tan CL; Oli Mohamed S; Iqbal T; Ibrahim N
Cureus; 2024 Apr; 16(4):e58507. PubMed ID: 38765367
[TBL] [Abstract][Full Text] [Related]
23. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease.
Soukiasian SH; Foster CS; Raizman MB
Am J Ophthalmol; 1994 Nov; 118(5):601-11. PubMed ID: 7977573
[TBL] [Abstract][Full Text] [Related]
24. [Cogan I syndrome: clinical aspects, therapy and prognosis].
Zierhut M; Schlote T; Stübiger N; Daikeler T; Kötter I; Bless D; Koitschev A
Ophthalmologe; 2000 Mar; 97(3):197-202. PubMed ID: 10789178
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
26. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
Bizzaro N; Villalta D; Giavarina D; Tozzoli R
Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
[TBL] [Abstract][Full Text] [Related]
27. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.
Ale'ed A; Alsonbul A; Al-Mayouf SM
Rheumatol Int; 2014 Apr; 34(4):529-33. PubMed ID: 24218286
[TBL] [Abstract][Full Text] [Related]
29. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease.
Yuan S; Ye Y; Chen D; Qiu Q; Zhan Z; Lian F; Li H; Liang L; Xu H; Yang X
Semin Arthritis Rheum; 2014 Jun; 43(6):759-66. PubMed ID: 24332116
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of episcleritis and scleritis in urban Australia.
Thong LP; Rogers SL; Hart CT; Hall AJ; Lim LL
Clin Exp Ophthalmol; 2020 Aug; 48(6):757-766. PubMed ID: 32279425
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and immunological characteristics of systemic lupus erythematosus with retinopathy].
Li M; Hou LQ; Jin YB; He J
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1106-1111. PubMed ID: 36533340
[TBL] [Abstract][Full Text] [Related]
32. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
33. [New clinical and epidemiologic aspects of episcleritis and scleritis].
Denk PO; Rohrbach JM; Thiel HJ; Zierhut M
Ophthalmologe; 1997 Mar; 94(3):202-5. PubMed ID: 9181836
[TBL] [Abstract][Full Text] [Related]
34. Episcleritis and scleritis.
White GE
Optom Clin; 1991; 1(4):79-87. PubMed ID: 1799838
[TBL] [Abstract][Full Text] [Related]
35. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
[TBL] [Abstract][Full Text] [Related]
36. Risks of ophthalmic disorders in patients with systemic lupus erythematosus - a secondary cohort analysis of population-based claims data.
Hsu CS; Hsu CW; Lu MC; Koo M
BMC Ophthalmol; 2020 Mar; 20(1):96. PubMed ID: 32160869
[TBL] [Abstract][Full Text] [Related]
37. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
38. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study.
Ahmed N; Shigidi M; Al Agib AN; Abdelrahman H; Taha E
Pan Afr Med J; 2017; 27():114. PubMed ID: 28819535
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE.
Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH
Lupus; 2002; 11(4):227-33. PubMed ID: 12043886
[TBL] [Abstract][Full Text] [Related]
40. Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study.
Bello N; Birt JA; Workman J; Zhou X; Ross-Terres JA; Petri M
Adv Ther; 2022 Jul; 39(7):3131-3145. PubMed ID: 35534786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
